Hero

African Cohort Study (AFRICOS)

AFRICOS logoIn 2013, MHRP initiated a large, long-term cohort study at multiple African sites that evaluates HIV prevention, care and  treatment services it supports through local facilities, funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). AFRICOS findings are impacting HIV policy and PEPFAR programming, including evidence-based antiretroviral therapy (ART) recommendations.

“AFRICOS helps us capture the broader picture of the overall health of our patients with HIV,” said COL Julie Ake, M.D., the study’s lead investigator. “Researchers are gaining a better understanding of what leads to the best clinical outcomes, which in turn facilitates the sharing of best practices between sites.” 

Where We Work

AFRICOS Map
                 Nigeria            Uganda            Kenya            Tanzania 
AFRICOS lab Uganda

Spotlight

MHRP’s African Cohort Study (AFRICOS), a multisite, long-term study that evaluates HIV prevention, care and treatment services it supports through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), is entering its ninth year in 2022. Over the past year, MHRP researchers and collaborators published 13 papers in peer-reviewed journals. A sampling of cohort research reveals the breadth of research conducted under AFRICOS: